SCHEMBL451490

SCHEMBL451490

[O]Cc1ccc(Cl)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3078068 0.81
SCHEMBL17201196 0.78
SCHEMBL17799 0.78
SCHEMBL28587025 0.77 ALDH1A1 (0.49)
SCHEMBL245979 0.77 ALDH1A1 (0.49)
Hydrochloric Acid SCHEMBL244808 0.76 GAA (0.50)
Hydrochloric Acid SCHEMBL7501190 0.76 GAA (0.50)
SCHEMBL2643692 0.76
SCHEMBL244807 0.76 GAA (0.50)
SCHEMBL4166547 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110746355-B Phenylpyrazole compound, pharmaceutical composition, and preparation method and application thereof 中国科学院上海有机化学研究所 2023-08-11 CN claimed
CN-110746355-A Phenylpyrazole compound, pharmaceutical composition, preparation method and application thereof 中国科学院上海有机化学研究所 2020-02-04 CN claimed
EP-3275877-A1 HERBICIDAL PYRIDINE COMPOUNDS BASF SE (DE) 2018-01-31 EP claimed
EP-2310009-B1 PARENTERAL AND ORAL FORMULATIONS OF BENZIMIDAZOLES UNIV HOUSTON (US) 2017-12-20 EP claimed
EP-2334175-B1 PHENYL-SUBSTITUTED BICYCLOOCTANE 1,3 DIONE DERIVATIVES BAYER IP GMBH (DE) 2017-03-01 EP claimed
US-9259391-B2 Parenteral and oral formulations of benzimidazoles THE UNIVERSITY OF HOUSTON SYSTEM (US) 2016-02-16 US claimed
US-9259390-B2 Parenteral and oral formulations of benzimidazoles THE UNIVERSITY OF HOUSTON SYSTEM (US) 2016-02-16 US claimed
US-8907096-B2 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2014-12-09 US claimed
US-20140357633-A1 COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2014-12-04 US claimed
EP-2794592-A1 COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS Novartis AG (CH) 2014-10-29 EP claimed
EP-0680472-A1 4,5-DIPHENYLIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ACYL COENZYME A: CHOLESTEROL-0-ACYL-TRANSFERASE (ACAT) INHIBITOR PHARMACIA &amp; UPJOHN S.p.A. (IT) 1995-11-08 EP claimed
WO-1995014673-A1 4,5-DIPHENYLIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ACYL COENZYME A: CHOLESTEROL-0-ACYL-TRANSFERASE (ACAT) INHIBITOR PHARMACIA S.P.A. (IT) 1995-06-01 WO claimed
EP-0628036-A4 N-SUBSTITUTED-FURYLALKENYL HYDROXAMIC ACID AND N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY. 1995-01-11 EP claimed
EP-0628036-A1 N-SUBSTITUTED-FURYLALKENYL HYDROXAMIC ACID AND N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1994-12-14 EP claimed
WO-1993017006-A1 N-SUBSTITUTED-FURYLALKENYL HYDROXAMIC ACID AND N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1993-09-02 WO claimed
US-5169854-A N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity ABBOTT LABORATORIES (US) 1992-12-08 US claimed
EP-0232075-B1 INSECTICIDAL N'-SUBSTITUTED-N-ALKYLCARBONYL-N'-ACYL HYDRAZINES ROHM AND HAAS COMPANY (US) 1991-03-13 EP claimed
US-4904777-A COLORFASTNESS BASF AKTIENGESELLSCHAFT (DE) 1990-02-27 US claimed
EP-0054974-B1 IMIDAZOLYLPROPANOL COMPOUNDS AND THEIR ACID ADDITION SALTS, AND PRODUCTION AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-07-10 EP claimed
US-4016263-A BACTERICIDES BOEHRINGER INGELHEIM GMBH (DT) 1977-04-05 US claimed